Mabioside A

(1R,2R,3R,5R,6R,9S,10R,14R,17S)-1,2,5,14,18,18-hexamethyl-6-(3-methylbut-2-enyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-4,7-dioxapentacyclo[11.8.0.02,10.05,9.014,19]henicosan-8-one

JDYBTMHCHWARHS-UZTDFSENSA-N CHEBI:185930 0 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
JDYBTMHCHWARHS-UZTDFSENSA-N
IUPAC name
(1R,2R,3R,5R,6R,9S,10R,14R,17S)-1,2,5,14,18,18-hexamethyl-6-(3-methylbut-2-enyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-4,7-dioxapentacyclo[11.8.0.02,10.05,9.014,19]henicosan-8-one
Preferred name
Mabioside A
INN name
Synonym
ChEBI
CHEBI:185930

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles